Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 5Completed 3Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Drug Therapy 107Cisplatin 98Radiotherapy 89Carboplatin 86Bevacizumab 79Oxaliplatin 74Capecitabine 69tislelizumab 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 58pembrolizumab 56Specimen Handling 54sintilimab 53Surgical Procedures, Operative 52anlotinib 51Magnetic Resonance Spectroscopy 50Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35Leucovorin 34lenvatinib 33venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Proton Pump Inhibitors × Clear all
NCT07076914 2025-07-22

PPI-PROTECT

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Not yet recruiting
58 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡